Brain PET Accelerator
Brain PET Accelerator
Comprehensive Imaging Program
Comprehensive Imaging Program
In-office Brain PET.
Profitable in Year One.
Fully Managed.
In-office
Brain PET.
Profitable in
Year One.
Fully Managed.
Positive margins at reasonable scan volumes, with zero capital outlay.
We handle the complexity, while you see the patients.
The Alzheimer's Care Pathway
Is Accelerating
PET Imaging is established as a standard of care in determining eligibility for Alzheimer's disease treatments.
With an estimated 9 million US adults carrying amyloid plaque, demand for confirmation imaging is accelerating fast.
For 2026, there's a projected 4x acceleration in PET confirmation and DMT prescription.
Practices with confirmation capacity are positioned to capture this growth.
~0M
~0M
Adults Living
with Amyloid Buildup
0x
0x
Projected Growth in Alzheimer's DMT Prescription
+0% YoY
+0% YoY
Growth in Brain PET Scan Demand
+0 months
+0 months
On Waitlist for
a Confirmation PET Scan
The Alzheimer's Care Pathway
Is Accelerating
PET Imaging is established as a standard of care in determining eligibility for Alzheimer's disease treatments.
With an estimated 9 million US adults carrying amyloid plaque, demand for confirmation imaging is accelerating fast.
For 2026, there's a projected 4x acceleration in PET confirmation and DMT prescription.
Practices with confirmation capacity are positioned to capture this growth.
~0M
~0M
Adults Living
with Amyloid Buildup
0x
0x
Projected Growth in Alzheimer's DMT Prescription
+0% YoY
+0% YoY
Growth in Brain PET Scan Demand
+0 months
+0 months
On Waitlist for
a Confirmation PET Scan
The Alzheimer's Care Pathway
Is Accelerating
PET Imaging is established as a standard of care in determining eligibility for Alzheimer's disease treatments.
With an estimated 9 million US adults carrying amyloid plaque, demand for confirmation imaging is accelerating fast.
For 2026, there's a projected 4x acceleration in PET confirmation and DMT prescription.
Practices with confirmation capacity are positioned to capture this growth.
~0M
~0M
Adults Living
with Amyloid Buildup
0x
0x
Projected Growth in Alzheimer's DMT Prescription
+0% YoY
+0% YoY
Growth in Brain PET Scan Demand
+0 months
+0 months
On Waitlist for
a Confirmation PET Scan
Anti‑amyloid therapy is most effective when initiated at the earliest stages of Alzheimer’s disease. Delays in obtaining confirmatory imaging risk disease progression beyond this therapeutic window.
Michael S. Rafii, MD, PhD,
Professor of Neurology, USC Keck School of Medicine
Medical Director, Epstein Family Alzheimer’s Therapeutic
Research Institute
Michael S. Rafii, MD, PhD,
Professor of Neurology,
USC Keck School of Medicine
Medical Director, Alzheimer's Therapeutic Research Institute
A Fully Managed Brain PET Model
Profitable from Year One
The Brain PET Accelerator Program
Site build-out
Site assessment, shielding, and installation. No construction project.
Site build-out
Site assessment, shielding, and installation. No construction project.
Regulatory compliance
RAM licensing, hot lab setup, and radiation safety — fully managed.
Regulatory compliance
RAM licensing, hot lab setup, and radiation safety — fully managed.
Technologist staffing
Certified nuclear medicine technologist included. No new hire, no training overhead.
Technologist staffing
Certified nuclear medicine technologist included. No new hire, no training overhead.
Radiotracer logistics
Same-day tracer delivery coordinated with a regional radiopharmacy.
Radiotracer logistics
Same-day tracer delivery coordinated with a regional radiopharmacy.
The Economics
$1M–$2.5M
Projected cumulative net profit over five years at moderate scan volumes.
$1M–$2.5M
Projected cumulative net profit over five years at moderate scan volumes.
$1M–$2.5M
Projected cumulative net profit over five years at moderate scan volumes.
Profitable from year one
At 30–40 amyloid scans per month, the program turns profitable in year one.
Profitable from year one
At 30–40 amyloid scans per month, the program turns profitable in year one.
$0 upfront
No capital outlay. Program costs align with scan volume, not a purchase.
$0 upfront
No capital outlay. Program costs align with scan volume, not a purchase.
One patient, full pathway
Confirmation and monitoring scans. Anti-amyloid therapy, MRI, all under one roof.
One patient, full pathway
Confirmation and monitoring scans. Anti-amyloid therapy, MRI, all under one roof.
Claim the Alzheimer's Care Pathway
Join the growing network of neurology practices bringing brain PET imaging in-house.
Claim the Alzheimer's Care Pathway
Join the growing network of neurology practices bringing brain PET imaging in-house.
Claim the Alzheimer's Care Pathway
Join the growing network of neurology practices bringing brain PET imaging in-house.
The Brain PET Scanner
that Fits in your Practice
The Brain PET
Scanner
that Fits in your
Practice
NeuroLF®
Purpose-built for Brain PET Imaging.
Patients sit and get scanned in 20 minutes.
It fits in existing clinical space,
without construction plan
or floor reinforcement, and plugs into a standard 110v wall outlet.
NeuroLF® Features
The First Dedicated Brain PET Scanner for Outpatient Neurology.
5.4 x 7.0 x 2.4 ft
Minimal Site Prep
Standard 110V Power Outlet
Minimal shielding needs
Patient-friendly upright design
Total footprint: ~175 sq ft (Scanning + Operator Room)
NeuroLF®
NeuroLF® Features
NeuroLF®
Purpose-built for Brain PET Imaging.
Patients sit and get scanned in 20 minutes.
It fits in existing clinical space,
without construction plan
or floor reinforcement,
and plugs into a standard 110v wall outlet.
Blueprint for Success
Blueprint for Success
Launching our Alzheimer’s & Dementia Center with NeuroLF at its core represents a transformation in how we can serve patients experiencing memory loss and cognitive symptoms.
Dr. Branko Huisa
Founder and Medical Director,
The Neuron Clinic, San Marcos, California
Launching our Alzheimer’s & Dementia Center with NeuroLF at its core represents a transformation in how we can serve patients experiencing memory loss and cognitive symptoms.
Dr. Branko Huisa
Founder and Medical Director,
The Neuron Clinic, San Marcos, California
Launching our Alzheimer’s & Dementia Center with NeuroLF at its core represents a transformation in how we can serve patients experiencing memory loss and cognitive symptoms.
Dr. Branko Huisa
Founder and Medical Director,
The Neuron Clinic, San Marcos, California
Neurology at the Center
With in-office brain PET, the entire Alzheimer's care pathway stays within your practice. One practice, one team, unified care from first suspicion to long-term monitoring.
FAQ
How much space is needed to install NeuroLF in a practice setting?
What’s included in the Brain PET Accelerator program?
What revenue and profit potential can a practice expect?
What upfront investment is required to get started?
Why is now the right time to add amyloid PET imaging to Alzheimer’s care?
Can I request a personalized pro forma for my practice?
How much space is needed to install NeuroLF in a practice setting?
What’s included in the Brain PET Accelerator program?
What revenue and profit potential can a practice expect?
What upfront investment is required to get started?
Why is now the right time to add amyloid PET imaging to Alzheimer’s care?
Can I request a personalized pro forma for my practice?